Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8399 USD | -3.35% | +11.99% | -55.32% |
08-30 | AmpliTech Says August Bookings Top $1 Million | MT |
08-28 | Transcript : AmpliTech Group, Inc., Q2 2024 Earnings Call, Aug 28, 2024 |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.17 | -18.55 | -16.78 | 0.47 | -4.73 | |||||
Return on Total Capital | 4.62 | -19.56 | -19.17 | 0.53 | -5.04 | |||||
Return On Equity % | 0.59 | -133.71 | -32.29 | -2.34 | -8.89 | |||||
Return on Common Equity | 0.59 | -133.71 | -32.29 | -2.34 | -8.89 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 50.15 | 36.27 | 24.5 | 46.02 | 46.68 | |||||
SG&A Margin | 45.06 | 62.76 | 86.53 | 39.35 | 48.2 | |||||
EBITDA Margin % | 6.82 | -23.83 | -94 | 3.51 | -13.13 | |||||
EBITA Margin % | 5.49 | -25.3 | -96 | 2.16 | -15.58 | |||||
EBIT Margin % | 5.09 | -26.49 | -96.78 | 1.39 | -16.54 | |||||
Income From Continuing Operations Margin % | 0.19 | -29.66 | -90.21 | -3.49 | -15.82 | |||||
Net Income Margin % | 0.19 | -29.66 | -90.21 | -3.49 | -15.82 | |||||
Net Avail. For Common Margin % | 0.19 | -29.66 | -90.21 | -3.49 | -15.82 | |||||
Normalized Net Income Margin | 1.66 | -18.54 | -57.97 | 0.83 | -10.26 | |||||
Levered Free Cash Flow Margin | -7.6 | -7.12 | -95.4 | -19.23 | -34.03 | |||||
Unlevered Free Cash Flow Margin | -6.86 | -5.14 | -94.89 | -19.19 | -34.03 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.31 | 1.12 | 0.28 | 0.54 | 0.46 | |||||
Fixed Assets Turnover | 7.4 | 5.32 | 3.4 | 4.46 | 2.52 | |||||
Receivables Turnover (Average Receivables) | 7.09 | 7.08 | 5.23 | 11.21 | 7.17 | |||||
Inventory Turnover (Average Inventory) | 3.28 | 4.1 | 1.69 | 1.93 | 1.26 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.6 | 2.13 | 6.36 | 12.08 | 11.44 | |||||
Quick Ratio | 2.29 | 0.85 | 5.21 | 8.36 | 6.18 | |||||
Operating Cash Flow to Current Liabilities | -0.04 | -0.8 | -0.58 | -1.87 | -2.31 | |||||
Days Sales Outstanding (Average Receivables) | 51.5 | 51.66 | 69.77 | 32.57 | 50.87 | |||||
Days Outstanding Inventory (Average Inventory) | 111.25 | 89.27 | 215.83 | 188.69 | 289.26 | |||||
Average Days Payable Outstanding | 25.49 | 22.67 | 74.35 | 54.67 | 37.91 | |||||
Cash Conversion Cycle (Average Days) | 137.26 | 118.26 | 211.25 | 166.6 | 302.22 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 189.87 | 509.31 | 5.4 | 16.25 | 14.41 | |||||
Total Debt / Total Capital | 65.5 | 83.59 | 5.13 | 13.98 | 12.59 | |||||
LT Debt/Equity | 159.62 | 389.93 | 3.49 | 13.59 | 12.01 | |||||
Long-Term Debt / Total Capital | 55.06 | 64 | 3.31 | 11.69 | 10.5 | |||||
Total Liabilities / Total Assets | 67.45 | 84.34 | 17.58 | 21.6 | 15.05 | |||||
EBIT / Interest Expense | 2.09 | -8.36 | -119.27 | 20.71 | - | |||||
EBITDA / Interest Expense | 3.5 | -7.52 | -115.84 | 52.37 | - | |||||
(EBITDA - Capex) / Interest Expense | 3.34 | -8.17 | -140.69 | -4.17 | - | |||||
Total Debt / EBITDA | 7.79 | -2.72 | -0.32 | 6.86 | -1.88 | |||||
Net Debt / EBITDA | 5.63 | -2.48 | 3.32 | -13.01 | 1.41 | |||||
Total Debt / (EBITDA - Capex) | 8.18 | -2.5 | -0.26 | -86.09 | -1.27 | |||||
Net Debt / (EBITDA - Capex) | 5.92 | -2.28 | 2.73 | 163.37 | 0.95 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 30.25 | 10.74 | 52.55 | 267.64 | -19.64 | |||||
Gross Profit, 1 Yr. Growth % | 13.38 | -19.91 | 3.06 | 590.44 | -18.48 | |||||
EBITDA, 1 Yr. Growth % | -44.02 | -487.13 | 501.72 | -113.74 | -399.57 | |||||
EBITA, 1 Yr. Growth % | -49.79 | -610.25 | 478.97 | -108.28 | -676.53 | |||||
EBIT, 1 Yr. Growth % | -53.43 | -676.08 | 457.39 | -105.28 | -1.05K | |||||
Earnings From Cont. Operations, 1 Yr. Growth % |